Lexeo Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,944 |
Gross Profit | -530 | -510 | -501 | 972 |
EBITDA | -19,731 | -25,534 | -32,115 | -25,373 |
EBIT | -20,261 | -26,044 | -32,616 | -25,894 |
Net Income | -20,283 | -26,103 | -32,656 | -25,924 |
Net Change In Cash | 0 | 0 | 0 | 1,944 |
Free Cash Flow | -29,836 | -27,327 | -21,716 | -28,313 |
Cash | 40,996 | 35,480 | 28,913 | 35,014 |
Basic Shares | 60,980 | 43,573 | 33,113 | 33,076 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $654 | $1,657 |
Gross Profit | -2,001 | -1,843 | 654 | 1,657 |
EBITDA | -96,194 | -64,346 | -58,041 | -50,609 |
EBIT | -98,196 | -66,189 | -59,186 | -50,622 |
Net Income | -98,333 | -66,394 | -59,277 | -50,622 |
Net Change In Cash | 0 | 0 | 654 | 1,657 |
Free Cash Flow | -81,632 | -59,661 | -55,461 | -44,370 |
Cash | 35,014 | 121,466 | 77,335 | 135,860 |
Basic Shares | 31,787 | 26,646 | 25,169 | 25,169 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.33 |
2025-06-30 | -$0.60 |
2025-03-31 | -$0.99 |
2024-12-31 | -$0.78 |
